These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15765121)

  • 1. VEGF contributes to mammary tumor growth in transgenic mice through paracrine and autocrine mechanisms.
    Schoeffner DJ; Matheny SL; Akahane T; Factor V; Berry A; Merlino G; Thorgeirsson UP
    Lab Invest; 2005 May; 85(5):608-23. PubMed ID: 15765121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
    Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
    Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2).
    Gonzalez RR; Cherfils S; Escobar M; Yoo JH; Carino C; Styer AK; Sullivan BT; Sakamoto H; Olawaiye A; Serikawa T; Lynch MP; Rueda BR
    J Biol Chem; 2006 Sep; 281(36):26320-8. PubMed ID: 16825198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice.
    Yamazaki M; Akahane T; Buck T; Yoshiji H; Gomez DE; Schoeffner DJ; Okajima E; Harris SR; Bunce OR; Thorgeirsson SS; Thorgeirsson UP
    Carcinogenesis; 2004 Sep; 25(9):1735-46. PubMed ID: 15166086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of vascular endothelial growth factor and its receptor Flk-1/KDR in promoting tumour angiogenesis in feline and canine mammary carcinomas: a preliminary study of autocrine and paracrine loops.
    Millanta F; Silvestri G; Vaselli C; Citi S; Pisani G; Lorenzi D; Poli A
    Res Vet Sci; 2006 Dec; 81(3):350-7. PubMed ID: 16556453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential gene expression in mouse mammary adenocarcinomas in the presence and absence of wild type p53.
    Cui XS; Donehower LA
    Oncogene; 2000 Dec; 19(52):5988-96. PubMed ID: 11146550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention activity of dipyridamole in the MMTV-PyMT transgenic mouse model of breast cancer.
    Wang C; Schwab LP; Fan M; Seagroves TN; Buolamwini JK
    Cancer Prev Res (Phila); 2013 May; 6(5):437-47. PubMed ID: 23447563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioluminescence imaging of vascular endothelial growth factor promoter activity in murine mammary tumorigenesis.
    Faley SL; Takahashi K; Crooke CE; Beckham JT; Tomemori T; Shappell SB; Jansen ED; Takahashi T
    Mol Imaging; 2007; 6(5):331-9. PubMed ID: 18092518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta regulator SnoN modulates mammary gland branching morphogenesis, postlactational involution, and mammary tumorigenesis.
    Jahchan NS; You YH; Muller WJ; Luo K
    Cancer Res; 2010 May; 70(10):4204-13. PubMed ID: 20460516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development.
    Oloumi A; Maidan M; Lock FE; Tearle H; McKinney S; Muller WJ; Aparicio SA; Dedhar S
    Breast Cancer Res; 2010; 12(3):R38. PubMed ID: 20565980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulation of vascular endothelial growth factor expression in epithelial and stromal cells during mouse mammary gland development.
    Hovey RC; Goldhar AS; Baffi J; Vonderhaar BK
    Mol Endocrinol; 2001 May; 15(5):819-31. PubMed ID: 11328861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptomic signature of cell lines isolated from canine mammary adenocarcinoma metastases to lungs.
    Król M; Polańska J; Pawłowski KM; Turowski P; Skierski J; Majewska A; Ugorski M; Morty RE; Motyl T
    J Appl Genet; 2010; 51(1):37-50. PubMed ID: 20145299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin deficiency limits tumor vascularization in the MMTV-PyV-mT mouse model of mammary cancer.
    Denzel MS; Hebbard LW; Shostak G; Shapiro L; Cardiff RD; Ranscht B
    Clin Cancer Res; 2009 May; 15(10):3256-64. PubMed ID: 19447866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin.
    Calvo A; Yokoyama Y; Smith LE; Ali I; Shih SC; Feldman AL; Libutti SK; Sundaram R; Green JE
    Int J Cancer; 2002 Sep; 101(3):224-34. PubMed ID: 12209972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of G1/S regulatory genes occurs early and frequently in lung carcinogenesis in transforming growth factor-beta1 heterozygous mice.
    Kang Y; Ozbun LL; Angdisen J; Moody TW; Prentice M; Diwan BA; Jakowlew SB
    Carcinogenesis; 2002 Jul; 23(7):1217-27. PubMed ID: 12117781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis.
    Calvo A; Catena R; Noble MS; Carbott D; Gil-Bazo I; Gonzalez-Moreno O; Huh JI; Sharp R; Qiu TH; Anver MR; Merlino G; Dickson RB; Johnson MD; Green JE
    Oncogene; 2008 Sep; 27(40):5373-84. PubMed ID: 18504437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity analysis in primary mammary tumors and lung metastases of MMTV-MTAg and MMTV-neu transgenic mice.
    Ritland SR; Rowse GJ; Chang Y; Gendler SJ
    Cancer Res; 1997 Aug; 57(16):3520-5. PubMed ID: 9270023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
    Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K
    Cancer Res; 2007 Aug; 67(15):7212-22. PubMed ID: 17671189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the vascular endothelial growth factor (VEGF) receptor Flk-1/KDR by estradiol through VEGF in uterus.
    Hervé MA; Meduri G; Petit FG; Domet TS; Lazennec G; Mourah S; Perrot-Applanat M
    J Endocrinol; 2006 Jan; 188(1):91-9. PubMed ID: 16394178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
    Kodama M; Kitadai Y; Tanaka M; Kuwai T; Tanaka S; Oue N; Yasui W; Chayama K
    Clin Cancer Res; 2008 Nov; 14(22):7205-14. PubMed ID: 19010837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.